525 related articles for article (PubMed ID: 31483853)
1. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Bhatt J; Jahnke N; Smyth AR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
[TBL] [Abstract][Full Text] [Related]
2. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J; Nevitt SJ
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
[TBL] [Abstract][Full Text] [Related]
3. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
[TBL] [Abstract][Full Text] [Related]
4. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
[TBL] [Abstract][Full Text] [Related]
5. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Tan KH
Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
[TBL] [Abstract][Full Text] [Related]
6. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
[TBL] [Abstract][Full Text] [Related]
7. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
Tan K; Bunn H
Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
[TBL] [Abstract][Full Text] [Related]
8. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
9. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
[TBL] [Abstract][Full Text] [Related]
10. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Rosenfeld M; Rayner O; Smyth AR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
Hurley MN; Smith S; Forrester DL; Smyth AR
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
[TBL] [Abstract][Full Text] [Related]
14. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Elphick HE; Scott A
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
[TBL] [Abstract][Full Text] [Related]
15. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
16. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Holland P; Jahnke N
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
[TBL] [Abstract][Full Text] [Related]
17. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
19. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
[TBL] [Abstract][Full Text] [Related]
20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Smith S; Ratjen F; Remmington T; Waters V
Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
